Latest Breaking News On - Coprincipal investigator david kandzari - Page 1 : comparemela.com

April 12, 2023—Ablative Solutions, Inc. announced the completion of patient enrollment in the TARGET BP I study, which is evaluating alcohol-med

United statesDavid kandzariPiedmont heart institute in atlantaAblative solutions incAblative solutionsCoprincipal investigator david kandzariInterventional cardiologyChief scientific officerPiedmont heart instituteRenal denervationTarget bpBlood pressure